MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy

Aim Hepatocellular carcinoma (HCC) develops in up to 5% of patients after the successful treatment of chronic hepatitis C virus (HCV) infection using interferon therapy. The aim of this study was to characterize miRNA expression in liver tissues from patients who achieved a sustained viral response...

Full description

Saved in:
Bibliographic Details
Published inHepatology research Vol. 46; no. 3; pp. E26 - E35
Main Authors Tamori, Akihiro, Murakami, Yoshiki, Kubo, Shoji, Itami, Saori, Uchida-Kobayashi, Sawako, Morikawa, Hiroyasu, Enomoto, Masaru, Takemura, Shigekazu, Tanahashi, Toshihito, Taguchi, Y-h., Kawada, Norifumi
Format Journal Article
LanguageEnglish
Published Netherlands Blackwell Publishing Ltd 01.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aim Hepatocellular carcinoma (HCC) develops in up to 5% of patients after the successful treatment of chronic hepatitis C virus (HCV) infection using interferon therapy. The aim of this study was to characterize miRNA expression in liver tissues from patients who achieved a sustained viral response (SVR). Methods Seventy‐one patients with resected HCC were enrolled into the present study: 61 HCC from patients with continuously infected HCV (HCV‐HCC) and 10 from patients who had achieved SVR (SVR‐HCC). We also included non‐tumor tissues (SVR‐NT) from four patients with SVR‐HCC, and liver tissue (SVR‐CH) from four SVR patients without HCC. Total RNA was extracted from liver samples. The miRNA expression patterns were analyzed using microarrays. In addition, target gene expression was quantified after miRNA overexpression in HEK293 cells. Results We could discriminate between SVR‐HCC and HCV‐HCC with 75.36% accuracy using the expression pattern of six specific miRNA. The expression levels of 37 miRNA were significantly lower in HCV‐HCC than in SVR‐HCC, whereas the expression of 25 miRNA was significantly higher in HCV‐HCC than SVR‐HCC (P < 1.0E‐05). The expression of thrombospondin 1 was regulated in an opposing manner by miR‐30a‐3p in SVR‐HCC and HCV‐HCC. In non‐tumor tissues, the expression pattern of seven miRNA could distinguish between SVR‐CH and SVR‐NT with 87.50% accuracy. Conclusion Comprehensive miRNA expression analyses could not only differentiate between SVR‐HCC and HCV‐HCC but also forecast hepatocarcinogenesis after achieving SVR.
Bibliography:ark:/67375/WNG-0LNWDCT9-9
istex:E5E663C123899B60BBCD70F578B4C6BBE8046CD0
ArticleID:HEPR12518
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1386-6346
1872-034X
DOI:10.1111/hepr.12518